OPKO Health (OPK) Current Ratio: History & Chart

OPKO Health, Inc.(OPK)

Medical - Diagnostics & Research · Miami, FL

$1.48-0.09 (-6.05%)

Delayed quote: Oct 6, 2026, 3:40 PM EDT

About OPKO Health, Inc.

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Kscore testing for prostate cancer. Within the Pharmaceutical segment, OPKO offers a range of therapeutic products and a robust development pipeline. Key offerings include Rayaldee, indicated for the management of secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The pipeline features OPK88004, an investigational orally administered selective androgen receptor modulator; OPK88003, a peptide administered once weekly currently in Phase IIb trials for the treatment of type 2 diabetes and obesity; and hGH-CTP, a once-weekly human growth hormone injection that has successfully completed Phase III clinical trials in collaboration with Pfizer, Inc. A core strategy for this segment involves the development and commercialization of proprietary, extended-release versions of existing therapeutic proteins. Furthermore, OPKO Health supplies specialty active pharmaceutical ingredients (APIs) and is involved in the development, manufacturing, marketing, and sale of pharmaceutical, nutraceutical, veterinary, and ophthalmic products. The company also commercializes food supplements and over-the-counter products, produces and sells items primarily within the generics market, and handles the import, marketing, distribution, and sales of pharmaceutical products across various therapeutic areas, including cardiovascular conditions, vaccines, antibiotics, gastro-intestinal ailments, and hormone-related treatments, among others. Its pharmaceutical operations are further bolstered by platforms situated in Ireland, Chile, Spain, and Mexico. Founded in 1991, OPKO Health, Inc. maintains its corporate headquarters in Miami, Florida.

Miami, FL

2,275 employees

www.opko.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Phillip Frost

View full financials

OPK Current Ratio Metrics

CURRENT RATIO

3.35

CURRENT RATIO AVG TTM

3.61

CURRENT RATIO AVG 3Y

2.75

CURRENT RATIO AVG 5Y

2.47

CURRENT RATIO AVG 10Y

1.89

CURRENT RATIO AVG 15Y

2.07

CURRENT RATIO AVG 20Y

2.10

CURRENT VS TTM AVG

-7.15%

CURRENT VS 3Y AVG

+21.88%

CURRENT VS 5Y AVG

+35.40%

CURRENT VS 10Y AVG

+77.59%

CURRENT VS 15Y AVG

+61.53%

CURRENT VS 20Y AVG

+59.73%

SECTOR MEDIAN · HEALTHCARE

3.75

median of 874 covered companies

CURRENT VS SECTOR MEDIAN

-10.69%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
OPKO Health, Inc. (OPK)	$1.10B	3.35	3.61	2.75	2.47
Replimune Group, Inc. (REPL)vs ›	$1.10B	5.23	6.37	10.25	15.62
Tandem Diabetes Care, Inc. (TNDM)vs ›	$1.10B	3.18	2.74	3.61	4.46
STAAR Surgical Company (STAA)vs ›	$1.10B	4.66	4.55	5.13	5.40
First Tracks Biotherapeutics Inc (TRAX)vs ›	$1.09B	14.28	10.49	14.28	14.28
IRadimed Corporation (IRMD)vs ›	$1.08B	9.46	8.41	7.63	9.11
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.08B	11.59	21.25	14.51	14.51
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.12B	33.10	10.19	10.19	10.19
Amphastar Pharmaceuticals, Inc. (AMPH)vs ›	$1.13B	2.40	3.54	3.31	3.13
Harrow Health, Inc. (HROW)vs ›	$1.13B	2.24	2.14	3.36	3.91

NAME

MARKET CAP

CURRENT RATIO

TTM

OPKO Health, Inc. (OPK)

$1.10B

3.35

3.61

2.75

2.47

Replimune Group, Inc. (REPL)vs ›

$1.10B

5.23

6.37

10.25

15.62

Tandem Diabetes Care, Inc. (TNDM)vs ›

$1.10B

3.18

2.74

3.61

4.46

STAAR Surgical Company (STAA)vs ›

$1.10B

4.66

4.55

5.13

5.40

First Tracks Biotherapeutics Inc (TRAX)vs ›

$1.09B

14.28

10.49

14.28

IRadimed Corporation (IRMD)vs ›

$1.08B

9.46

8.41

7.63

9.11

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.08B

11.59

21.25

14.51

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.12B

33.10

10.19

Amphastar Pharmaceuticals, Inc. (AMPH)vs ›

$1.13B

2.40

3.54

3.31

3.13

Harrow Health, Inc. (HROW)vs ›

$1.13B

2.24

2.14

3.36

3.91

Current Ratio FAQ

What is the current ratio for OPKO Health, Inc. (OPK)?

The current ratio for OPK stock is 3.35.

Is OPKO Health, Inc.'s current ratio high or low?

The current ratio of 3.35 is 35% above its 5-year average of 2.47, near the high end of its 5-year range (1.55–3.97).

What is the TTM average current ratio for OPKO Health, Inc. (OPK)?

The TTM average current ratio for OPK stock is 3.61.

What is the 3Y average current ratio for OPKO Health, Inc. (OPK)?

The 3Y average current ratio for OPK stock is 2.75.

What is the 5Y average current ratio for OPKO Health, Inc. (OPK)?

The 5Y average current ratio for OPK stock is 2.47.

What is the 10Y average current ratio for OPKO Health, Inc. (OPK)?

The 10Y average current ratio for OPK stock is 1.89.

What is the 15Y average current ratio for OPKO Health, Inc. (OPK)?

The 15Y average current ratio for OPK stock is 2.07.

What is the 20Y average current ratio for OPKO Health, Inc. (OPK)?

The 20Y average current ratio for OPK stock is 2.10.

DATE	CURRENT RATIO
2026-06-30	3.35
2026-03-31	3.61
2025-12-31	3.97
2025-09-30	3.70
2025-06-30	3.41
2025-03-31	2.49
2024-12-31	3.43
2024-09-30	2.97
2024-06-30	1.63
2024-03-31	1.91
2023-12-31	1.55
2023-09-30	1.78
2023-06-30	1.92
2023-03-31	1.83
2022-12-31	1.85
2022-09-30	1.55
2022-06-30	2.30
2022-03-31	2.44
2021-12-31	2.49
2021-09-30	1.97
2021-06-30	1.80
2021-03-31	1.48
2020-12-31	1.39
2020-09-30	1.27
2020-06-30	1.29
2020-03-31	1.12
2019-12-31	1.30
2019-09-30	1.08
2019-06-30	1.21
2019-03-31	1.10
2018-12-31	1.24
2018-09-30	0.91
2018-06-30	1.05
2018-03-31	1.21
2017-12-31	1.12
2017-09-30	1.66
2017-06-30	1.67
2017-03-31	1.74
2016-12-31	1.84
2016-09-30	1.97
2016-06-30	1.80
2016-03-31	1.70
2015-12-31	1.80
2015-09-30	1.45
2015-06-30	1.54
2015-03-31	2.16
2014-12-31	1.72
2014-09-30	2.12
2014-06-30	2.30
2014-03-31	2.43
2013-12-31	2.64
2013-09-30	3.38
2013-06-30	3.87
2013-03-31	4.08
2012-12-31	1.50
2012-09-30	1.89
2012-06-30	2.91
2012-03-31	3.35
2011-12-31	5.30
2011-09-30	5.81
2011-06-30	5.93
2011-03-31	5.78
2010-12-31	1.96
2010-09-30	2.20
2010-06-30	2.69
2010-03-31	2.10
2009-12-31	4.90
2009-09-30	16.52
2009-06-30	7.92
2009-03-31	0.88
2008-12-31	1.75
2008-09-30	2.33
2008-06-30	1.59
2008-03-31	2.39
2007-12-31	3.00
2007-09-30	0.89
2007-06-30	1.08
2007-03-31	2.94
2006-12-31	12.99
2006-09-30	23.11
2006-06-30	33.87
2006-03-31	29.55
2005-12-31	32.49
2005-09-30	415.00
2005-06-30	58.41
2005-03-31	50.22
2004-12-31	42.13
2004-09-30	35.57
2004-06-30	41.69
2004-03-31	26.18
2003-12-31	10.92
2003-09-30	19.14
2003-06-30	15.70
2003-03-31	20.26
2002-12-31	12.95
2002-09-30	21.22

DATE

CURRENT RATIO

2026-06-30

3.35

2026-03-31

3.61

2025-12-31

3.97

2025-09-30

3.70

2025-06-30

3.41

2025-03-31

2.49

2024-12-31

3.43

2024-09-30

2.97

2024-06-30

1.63

2024-03-31

1.91

2023-12-31

1.55

2023-09-30

1.78

2023-06-30

1.92

2023-03-31

1.83

2022-12-31

1.85

2022-09-30

1.55

2022-06-30

2.30

2022-03-31

2.44

2021-12-31

2.49

2021-09-30

1.97

2021-06-30

1.80

2021-03-31

1.48

2020-12-31

1.39

2020-09-30

1.27

2020-06-30

1.29

2020-03-31

1.12

2019-12-31

1.30

2019-09-30

1.08

2019-06-30

1.21

2019-03-31

1.10

2018-12-31

1.24

2018-09-30

0.91

2018-06-30

1.05

2018-03-31

1.21

2017-12-31

1.12

2017-09-30

1.66

2017-06-30

1.67

2017-03-31

1.74

2016-12-31

1.84

2016-09-30

1.97

2016-06-30

1.80

2016-03-31

1.70

2015-12-31

1.80

2015-09-30

1.45

2015-06-30

1.54

2015-03-31

2.16

2014-12-31

1.72

2014-09-30

2.12

2014-06-30

2.30

2014-03-31

2.43

2013-12-31

2.64

2013-09-30

3.38

2013-06-30

3.87

2013-03-31

4.08

2012-12-31

1.50

2012-09-30

1.89

2012-06-30

2.91

2012-03-31

3.35

2011-12-31

5.30

2011-09-30

5.81

2011-06-30

5.93

2011-03-31

5.78

2010-12-31

1.96

2010-09-30

2.20

2010-06-30

2.69

2010-03-31

2.10

2009-12-31

4.90

2009-09-30

16.52

2009-06-30

7.92

2009-03-31

0.88

2008-12-31

1.75

2008-09-30

2.33

2008-06-30

1.59

2008-03-31

2.39

2007-12-31

3.00

2007-09-30

0.89

2007-06-30

1.08

2007-03-31

2.94

2006-12-31

12.99

2006-09-30

23.11

2006-06-30

33.87

2006-03-31

29.55

2005-12-31

32.49

2005-09-30

415.00

2005-06-30

58.41

2005-03-31

50.22

2004-12-31

42.13

2004-09-30

35.57

2004-06-30

41.69

2004-03-31

26.18

2003-12-31

10.92

2003-09-30

19.14

2003-06-30

15.70

2003-03-31

20.26

2002-12-31

12.95

2002-09-30

21.22

Current Ratio: 3.35

OPK Current Ratio

OPK Average Current Ratio Chart

OPK Current vs Average Current Ratio Chart

OPK Current Ratio Metrics

OPK Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

OPK Current Ratio History

Related Metrics